Agile Therapeutics, Inc. (AGRX) Financials
AGRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 10.9 million | 23.3 million |
2023-06-30 | 12.6 million | 24.7 million |
2023-03-31 | 13.7 million | 23.1 million |
2022-12-31 | 14.2 million | 19.8 million |
AGRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | 365000 | 439000 |
2023-06-30 | -8.5 million | 481000 |
2023-03-31 | -1.6 million | 498000 |
2022-12-31 | -1.6 million | 524000 |
AGRX Net Income
No data available :(
AGRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 2.9 million | - | 549000 |
2023-06-30 | 2.8 million | - | 630000 |
2023-03-31 | 4.4 million | - | 708000 |
2022-12-31 | 5.2 million | - | 785000 |
AGRX Shares Outstanding
AGRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 705000 | 2.7 million | 4.8 million |
2023-06-30 | - | 703000 | 3.0 million | 4.6 million |
2023-03-31 | - | 763000 | 3.1 million | 4.7 million |
2022-12-31 | 7000 | 352000 | 2.0 million | 6.8 million |
AGRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 6.7 million | 2.5 million |
2023-06-30 | 5.5 million | 2.3 million |
2023-03-31 | 3.8 million | 2.0 million |
2022-12-31 | 4.0 million | 1.7 million |
AGRX
Price: $0.40
52 week price:
Earnings Per Share: -6.71 USD
P/E Ratio: 0.21
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 296349
Ebitda: -6.6 millionMarket Capitalization: 2.5 million